"It's become one of those terms that means so many things it almost means nothing."
Geoff Smith, founder and managing partner of Digitalis Ventures, on the term 'digital health'

"In our study, the activity of androgen synthesis in the newly generated Leydig-like cells, like natural Leydig cells, was triggered by luteinizing hormone in vitro and regulated by the hypothalamus-pituitary-gonad axis in vivo. Therefore, normal levels of serum testosterone can be maintained, including physiological pulses."
Zhijian Su, an associate professor in the Department of Cell Biology at Jinan University, on the development of the first stem cell-based treatment strategy for androgen deficiency due to male hypogonadism, whereby adult rodent skin cells are directly converted into functional testosterone-producing Leydig-like cells

"When we put patients in clinical trials, we can basically mandate high-quality care, state-of-the-art care. However, in general practice, physicians aren't the best at titrating statins. They tend to start a medicine and not necessarily optimize it over time. We also, sadly, miss some patients [who] need to be on these therapies."
Scott Wasserman, vice president of global development, Amgen Inc., on a new, 5,000-patient observational study that will "cast a more focused light on the unmet need" in knocking down levels of low-density lipoprotein cholesterol, as researchers will take "multiple snapshots" over a three-year period